U.S. Hotel and Resort REITs Stock News

NasdaqGS:ENSG
NasdaqGS:ENSGHealthcare

Ensign Group (ENSG) Stock Looks Reasonably Priced With Some Room To Rise

Ensign Group stock has delivered a strong 112.1% return over the past 5 years, yet the latest valuation work suggests the intrinsic value estimate still sits ahead of the current price while the broader checks do not flag the shares as a clear bargain. Ensign Group's 112.1% total return over 5 years shows the stock has already rewarded long term holders. Any further upside now matters more for new buyers who are considering entry points. Expectations for continued cash generation from its...
NasdaqGS:STGW
NasdaqGS:STGWMedia

Stagwell (STGW) Stock Stalls Despite Record Growth And Margin Gains

Stagwell stock barely flinched after earnings, slipping less than 1% to about US$8.45, even as the company reported its strongest second quarter on record. For a stock that has climbed more than 30% over the past three months, that muted move suggests investors are still weighing whether the latest numbers justify the recent run. The headline figures are clear: Stagwell posted record Q2 revenue of US$786.3m with double digit organic growth and adjusted EPS of US$0.25. The key question now is...
NYSE:GVA
NYSE:GVAConstruction

Granite Construction (GVA) Stock Rallies On Backlog Growth And Cash Flow Focus

Granite Construction stock jumped 5.3% to US$120.97 after the Q2 print, a sharp pivot from a tough recent stretch that left shares down about 19% over the past month and 13% over the past quarter. The market is reacting to a construction story built on scale, not cosmetics. Quarterly revenue reached about US$1.46b and adjusted net income was reported at US$101m, even as headline earnings per share reflected large non operating charges. For investors thinking beyond today’s pop, the key issue...
NYSE:RS
NYSE:RSMetals and Mining

Is Reliance (RS) Stock Priced For Too Much Optimism?

Reliance stock has delivered a strong 188.3% total return over the past 5 years, yet its current valuation checks flag the shares as expensive rather than a clear bargain. Reliance has returned 188.3% over 5 years, which puts extra focus on whether the current price still leaves enough room for long term returns to justify that track record. Future revenue and cash flow expectations can support the current share price. Any disappointment in growth or pressure on margins may quickly weigh on...
NasdaqGS:MNDY
NasdaqGS:MNDYSoftware

monday.com (MNDY) Is Up 12.6% After 20% Layoffs To Double Down On AI Work Platform – What's Changed

In July 2026, monday.com announced a restructuring plan to focus on its AI Work Platform, cutting about 20% of its workforce and expecting US$45 – US$55 million in related net charges, while continuing to hire in key areas this year. Despite the layoffs and restructuring costs, the company reaffirmed its 2026 revenue growth guidance of 19%–20%, indicating confidence in its AI-focused operating model. Next, we'll examine how this sizeable workforce reduction and AI focus might reshape...
NYSE:GHC
NYSE:GHCConsumer Services

Graham Holdings (GHC) Stock Profit Surge Raises Repeatability Questions

Graham Holdings stock slipped about 1.8% the day after earnings, which looks modest next to what the numbers just revealed. Q2 basic earnings per share landed at about US$65.91 on revenue of roughly US$1.30b, a sharp step up from the prior quarter’s US$6.68 per share on US$1.24b. For a company long viewed as a conservative compounder with a low 9.6x trailing P/E and a compressed 10.7% net margin over the last year, this kind of profit swing is the headline investors will be dissecting...
NasdaqGS:INBK
NasdaqGS:INBKBanks

First Internet Bancorp (INBK) Stock Jumps As Credit Stress Finally Eases

First Internet Bancorp stock ripped 12% higher to US$29.46 after its Q2 report, a sharp move for a regional online bank that has spent the past year wrestling with credit issues. The market is cheering one thing above all else: credit stress finally looks as if it is easing, with non performing loans and delinquencies moving lower while the bank still produced US$0.27 in earnings per share on US$41.1m of revenue. The question now is whether this one day surge reflects a genuine shift in risk...
NYSE:SPHR
NYSE:SPHREntertainment

Sphere Entertainment (SPHR) Stock Faces Loss Pressure As Venue Ambitions Grow

Sphere Entertainment stock closed at US$143.25, down 3.4% on the day, after a choppy few months that left the 30 day return down about 15%. The market focused on fresh losses in the quarter, with basic earnings per share of US$1.07 in the red and net income excluding extra items at a loss of US$38.8 million. The bigger story sits further out. Management is leaning into the Sphere venue model, with the Las Vegas asset generating US$226.4 million of segment revenue and US$39.9 million of...
NYSE:UNP
NYSE:UNPTransportation

Union Pacific (UNP) Could Be 11% Below Fair Value As Earnings And Dividend Lift Sentiment

Union Pacific (UNP) is back in focus after a cluster of shareholder friendly updates, including a 3% dividend hike, fresh earnings figures, and a new cross border rail agreement with Canadian National Railway. See our latest analysis for Union Pacific. Union Pacific’s recent dividend increase, earnings release, and cross border agreement have come alongside firm share price momentum, with a 30 day share price return of 5.2% and a 1 year total shareholder return of 36.2% pointing to steady...
NasdaqGM:CSTL
NasdaqGM:CSTLHealthcare

Castle Biosciences (CSTL) Stock Climbs On Higher Sales Outlook Despite Margin Pressure

Castle Biosciences stock came into the print already on a strong run, with double digit gains over the past month, then jumped another 4.5% to about US$28 after the Q2 release. That kind of move suggests traders see more than just a routine quarter. The headline is simple: Revenue reached US$103.5m and management lifted full year sales guidance, while the income statement still showed a small loss. The market is clearly focusing on the stronger top line and higher outlook more than the loss,...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

LKQ (LKQ) Stock Faces Profit Reset After Guidance Cut

LKQ stock barely flinched after earnings, slipping about 0.7% to US$22.45, even though the story behind the numbers is heavier than that move suggests. The headline is simple: earnings power is under pressure. Adjusted earnings per share landed at US$0.67 for the quarter while the company cut full year adjusted earnings guidance to US$2.60 to US$2.90 and trimmed its free cash flow outlook. For long term holders, the question now is whether a lower bar on profits and cash generation is a...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Fiserv (FISV) Is Up 5.7% After JANA Presses For Portfolio Review And Board Changes – Has The Bull Case Changed?

On July 30, 2026, activist investor JANA Partners sent a letter to Fiserv’s Board supporting a potential sale of its debit network assets and urging a formal, comprehensive review of the entire portfolio alongside further Board changes to address governance concerns. JANA’s push follows management turnover, what it describes as an earnings reset, and a very large share price decline from 2025 highs, framing a possible turnaround through portfolio divestitures and governance reform as a way...
NasdaqGS:FSLR
NasdaqGS:FSLRSemiconductor

First Solar (FSLR) Stock Climbs On Rich Margins As Policy Risk Lingers

First Solar stock added 2.4% to about US$211, even after a flat three months, as investors absorbed an earnings release built around one clear story: profitability. The quarter delivered a gross margin of about 57% and trailing net profit margins of 32.5% with net income of US$423 million, which is a notably strong combination for a hardware heavy solar manufacturer. Short term traders are reacting to the headline print. Long term holders are more likely focused on whether this kind of margin...
NYSE:MA
NYSE:MADiversified Financial

Mastercard (MA) Stock Dips As Profit Engine Fuels Valuation Debate

Mastercard stock slipped about 1% today, a modest pullback for a company that just reported another quarter of strong profits. The market reaction looks cautious rather than panicked. Q2 basic earnings per share came in at about US$4.98 on revenue of US$9.3b, with net income of roughly US$4.4b, which kept profitability firmly in focus. The central story for Mastercard is its profit engine. Net profit margin over the last year sat in the mid 40s, which is uncommon for a global payments...
NasdaqGS:LNT
NasdaqGS:LNTElectric Utilities

Alliant Energy (LNT) Stock Faces Flat Earnings And Margin Compression

Alliant Energy stock barely flinched after earnings, slipping about 0.2% on the day, even though the results gave investors more to consider than the price suggests. The company delivered Q2 2026 basic earnings per share of about US$0.66 and net income of US$170 million, numbers that sit within a steady but closely watched profit story. The real story for Alliant Energy is a subtle squeeze. Trailing 12 month earnings are essentially flat and net margin over the past year has eased, while the...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Neurocrine Biosciences (NBIX) Is Down 5.2% After Earnings Beat And Raised INGREZZA Outlook Has The Bull Case Changed?

In the second quarter of 2026, Neurocrine Biosciences reported revenue of US$959.0 million and net income of US$144.4 million, with earnings per share rising year over year, while six‑month revenue reached US$1.77 billion and net income US$342.3 million. The company also deepened its leadership bench with new senior appointments in market access, intellectual property, finance, and business development, aligning management capabilities with its broadened commercial portfolio and...
NYSE:CE
NYSE:CEChemicals

Should Amsterdam Court’s Rejection of Ethylene Claims Reshape Legal Risk Expectations for Celanese (CE)?

In July 2026, Celanese Corporation reported that the Amsterdam District Court dismissed in full a damages claim by Shell Chemicals Europe B.V. and a separate declaratory liability claim brought by certain Repsol entities via Stichting Ethylene Claims, both linked to follow-on litigation from a 2020 European Commission settlement over past ethylene purchases in North-Western Europe. This legal outcome removes a layer of uncertainty around potential ethylene-related liabilities for Celanese,...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

Sirius XM (SIRI) Stock Slips As Profit Improves But Debt Questions Persist

Sirius XM Holdings stock has slipped about 4% to US$29.62 in the first full trading day after earnings, even though the headline numbers were solidly in the black. Q2 net income reached US$239 million with basic earnings per share of US$0.71, and free cash flow surged, helped by tight cost control. In the very short term you are watching a pullback in a stock that had already logged a positive 90 day return. Over a longer horizon the real story is the tension between improving profitability...
NYSE:ELV
NYSE:ELVHealthcare

Elevance Health (ELV) Launches Connected Cancer Care With Predictive Analytics And Oncology Support

Elevance Health (NYSE:ELV) has introduced an enhanced connected cancer care model that uses predictive analytics, certified oncology navigators, and digital tools to tailor support for patients. The program is designed to coordinate care, target avoidable hospitalizations, and provide ongoing assistance throughout the cancer treatment journey. Elevance Health launched this expanded oncology model as its stock traded at $375.84, with a return of 39.7% over the past year and 6.1% year to...
NasdaqGS:STX
NasdaqGS:STXTech

Seagate Technology Holdings (STX) Lifted Fiscal 2027 Guidance, Is More Upside Already Priced In?

Seagate Technology Holdings (STX) is back in focus after reporting much stronger quarterly and full year results, issuing upbeat fiscal 2027 guidance and highlighting long term demand visibility from AI and cloud customers. See our latest analysis for Seagate Technology Holdings. The strong earnings, dividend affirmation and fresh fiscal 2027 guidance have come on top of a powerful run in Seagate Technology Holdings, with the stock posting a 17.74% 90 day share price return and a very large 1...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

How Investors Are Reacting To Palantir Technologies (PLTR) Pentagon Maven AI Momentum Ahead Of Q2 Earnings

In late July, investors focused on Palantir Technologies ahead of its August 3 second-quarter 2026 earnings release, as expectations centered on strong AI-driven revenue growth and heightened U.S. government demand, including its Maven AI system gaining Pentagon program-of-record status. At the same time, questions about commercial adoption, international contract renewals, and how effectively Palantir can convert intense AI interest into sustainable earnings have become increasingly...
NYSE:CL
NYSE:CLHousehold Products

What Colgate-Palmolive (CL)'s Q2 2026 Margin Squeeze And Steady Guidance Mean For Shareholders

Colgate-Palmolive’s second-quarter 2026 results showed sales rising to US$5,361 million from US$5,110 million a year earlier, while net income and earnings per share eased, and the company kept its full-year 2026 outlook for 2% to 6% net sales growth and double-digit GAAP EPS growth. The combination of higher sales but softer profitability, alongside management’s decision to maintain guidance despite ongoing cost and margin pressures, highlights a focus on sustaining growth while absorbing...
NYSE:WU
NYSE:WUDiversified Financial

Western Union (WU) Stock Sinks As Margin Pressure Deepens

Western Union just took a 17% hit, with the stock closing at US$6.36 after its Q2 earnings. That is a sharp move for a mature payments company and indicates the market is focused on near term pain. The main issue is margin pressure. Adjusted earnings per share landed at US$0.31, below last year, and the trailing net profit margin now sits at 9.8% compared with 21.8% a year ago. Short term traders are reacting to that squeeze. Longer term investors are weighing a low P/E near 5x and a double...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Veracyte (VCYT) Stock Sinks As Profit Strength Meets Reimbursement Doubt

Veracyte stock just dropped 22% to US$46.32, even though the quarter delivered what many long term investors say they want. Revenue reached US$150.3m and net income came in at US$25.5m, with adjusted earnings before interest, tax, depreciation and amortization at US$44m, equal to 29.2% of sales. That is a rich margin in diagnostics testing. The short term verdict is clear on your screen. The longer term question is whether a business that now generates this level of profit and cash can...